ADAMTS-13 and von Willebrand factor: a dynamic duo

87Citations
Citations of this article
114Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Summary: von Willebrand factor (VWF) is a key player in hemostasis, acting as a carrier for factor VIII and capturing platelets at sites of vascular damage. To capture platelets, it must undergo conformational changes, both within its A1 domain and at the macromolecular level through A2 domain unfolding. Its size and this function are regulated by the metalloproteinase ADAMTS-13. Recently, it has been shown that ADAMTS-13 undergoes a conformational change upon interaction with VWF, and that this enhances its activity towards its substrate. This review summarizes recent work on these conformational transitions, describing how they are controlled. It points to their importance in hemostasis, bleeding disorders, and the developing field of therapeutic application of ADAMTS-13 as an antithrombotic agent in obstructive microvascular thrombosis and in cardiovascular disease.

Cite

CITATION STYLE

APA

South, K., & Lane, D. A. (2018, January 1). ADAMTS-13 and von Willebrand factor: a dynamic duo. Journal of Thrombosis and Haemostasis. Blackwell Publishing Ltd. https://doi.org/10.1111/jth.13898

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free